Tim Hembree, DO, PhD

Dr. Hembree is interim chair of the Department of Internal and Hospital Medicine (IHM). The department is made up of hospitalists, ambulatory internal medicine doctors, the specialty of infectious disease as well as advanced practice professionals (APPs). We provide inpatient management of patients, consultative service for surgical patients, post-acute hospitalization follow-up, preoperative risk assessment and chronic disease management in the outpatient ambulatory medicine clinic. Dr. Hembree has been involved in the design of our care delivery models in all these care settings.

He also serves as Vice President, Chief Quality Officer at Moffitt Cancer Center. His responsibilities include oversight of quality department, quality metrics reporting both externally and internally, regulatory readiness, risk management and infection prevention.

Dr. Hembree received his DO degree at Nova Southeastern University College of Osteopathic Medicine in Davie, Florida, and his PhD degree in Biochemistry at the University of Texas, Health Science Center, in San Antonio. He completed an Internal Medicine Residency at Northside Hospital in St. Petersburg, Florida.

Dr. Hembree’ s research interest is focused on frailty in the hospitalized cancer patient. Dr. Hembree’ s clinical focus is on the care of patients with preexisting/chronic illness or medical conditions, such as diabetes, COPD, and HTN, that require inpatient hospitalization during their cancer treatment. He also focuses on acute problems that arise during cancer treatment.

Education & Training

Residency:

• Northside Hospital - Internal Medicine

Medical School:

• Nova Southeastern University College of Osteopathic Medicine - DO

• Lin YC, Turner K, Rajasekhara S, Kim DW, de Castria TB, Nguyen OT, Hume E, Sprow O, Santiago C, Milano J, Riccardi D, Nardella N, Al-Jumayli M, Permuth JB, Hoffe S, Hembree T, Hong YR, Islam JY, Tabriz AA, Hodul PJ. Early Supportive and Nutritional Care For Adults With Pancreatic Cancer: A Pilot Study. J Pain Symptom Manag. 2025 Nov.70(5):490-502. Pubmedid: 40816695.
• Lee G, Benyahia S, Syed M, Thakkar H, Reich R, Lochner J, Isenalumhe L, Hembree T, Verma N, Abdallah E. QIM25-218: Improving Quality Outcomes Through a Hospitalist-Driven Malignant Hematology Service. J Natl Compr Canc Ne. 2025 Mar.23(3.5). Pubmedid: 40154296.
• Afiat TN, Jalali S, McCain C, Jayson A, Thakkar H, Eaton K, Hembree TN, Verma N. An Atypical Presentation of Sweet's Syndrome in a Patient With Neutropenia: A Case Report. Cureus. 2025 Feb.17(2):e79023. Pubmedid: 40099100. Pmcid: PMC11911253.
• Hoogland CE, Sutton SK, Fennell BS, Simmons VN, Vinci C, Naqa IE, Salloum RG, Shete SS, Hembree T, Vidrine DJ, Vidrine JI. Early Treatment Engagement and Long-Term Smoking Abstinence Among Women With Cervical Intraepithelial Neoplasia or Cervical Cancer. AJPM Focus. 2025 Aug.4(4):100361. Pubmedid: 40673008. Pmcid: PMC12264617.
• Thakkar K, Khurana S, Sun Y, Hembree TN. Diabetic Ketoacidosis and Profound Insulin Resistance From Brentuximab Vedotin. Cureus. 2023 Mar.15(3):e35804. Pubmedid: 37025732. Pmcid: PMC10074015.
• Crowder SL, Hoogland AI, Small BJ, Carpenter KM, Fischer SM, Li D, Kinney AY, Welniak TL, Brownstein N, Reich RR, Hembree T, Extermann M, Kim R, Afiat TP, Berry DL, Turner K, Jim HSL. Associations among frailty and quality of life in older patients with cancer treated with chemotherapy. Geriatr Oncol. 2022 Nov.13(8):1149-1155. Pubmedid: 36008271. Pmcid: PMC9871794.
• Crowder SL, Welniak TL, Hoogland AI, Small BJ, Rodriguez Y, Carpenter KM, Fischer SM, Li D, Kinney AY, Rotroff D, Mariam A, Brownstein N, Reich RR, Hembree T, Playdon MC, Arthur AE, Vieytes CA, Li Z, Extermann M, Kim R, Berry DL, Jim HSL. Diet quality indices and changes in cognition during chemotherapy. Support Care Cancer. 2022 Dec.31(1):75. Pubmedid: 36544032. Pmcid: PMC10127432.
• Hembree T, Theou O, Thirlwell S, Reich RR, Cao B, Sehovic M, Syed M, Verma N, Nguyen TC, Keerty D, Wesolow J, Koverzhenko V, Extermann M, Huang J, Ramsakal A. A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study. Cancer Med. 2021 Sep.10(17):5765-5774. Pubmedid: 34350715. Pmcid: PMC8419777.
• Seok K, Hallanger-Johnson J, Holmstrom B, Hembree T, Sharda E, Ramsakal A, Verma N. Literally Malignant Hypertension. SN Compr Clin Med. 2021 May.3:1960-1964.
• Afiat TN, Hembree TN, Dean EA, Araujo C, Pena LR, Rosa M, Han HS, Hendrix K, Ramsakal A. Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose Adriamycin. Am J Case Rep. 2020 Sep.21:e924141. Pubmedid: 32877389. Pmcid: PMC7491943.
• Keerty D, Das M, Hembree TN, Ramsakal A, Haynes E. Lymphocele Containing Staphylococcus lugdunensis. Cureus. 2020 Nov.12(11):e11666. Pubmedid: 33391904. Pmcid: PMC7769740.
• Keerty D, Graham L, Haynes E, Hembree TN. Flexural Exanthema From Enfortumab Vedotin. Cureus. 2020 May.12(5):e8102. Pubmedid: 32542157. Pmcid: PMC7292715.
• Hembree TN, Thirlwell S, Reich RR, Pabbathi S, Extermann M, Ramsakal A. Predicting survival in cancer patients with and without 30-day readmission of an unplanned hospitalization using a deficit accumulation approach. Cancer Med. 2019 Nov.8(15):6503-6518. Pubmedid: 31493342. Pmcid: PMC6825978.
• Hembree TN, Teer JK, Hakam A, Chiappori AA. Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis. Cancer Control. 2016 Jan.23(1):61-66. Pubmedid: 27009459.
• Hembree TN, Leeb-Lundberg LM. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms. J Cell Physiol. 1996 Nov.169(2):248-255. Pubmedid: 8908192.

Voted top doctor in Internal Medicine in Tampa Magazine's Top Doctors 2025.

Voted top doctor in Internal Medicine in Tampa Magazine's Top Doctors 2024.